ACS P2Y12 Selection — EECC MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Ticagrelor
Ticagrelor is preferred over clopidogrel for ACS and is effective in clopidogrel nonresponders. Prasugrel is contraindicated with prior stroke/TIA. Withholding P2Y12 (D) is inappropriate. Dipyridamole (E) is not used in ACS.
Reference: ACC/AHA/SCAI Guideline (2021): Coronary Artery Revascularization